Anne E. Daigle - Concepedia

Author

Anne E. Daigle

Response Technologies (United States)

Also Known As

A Daigle, A E Daigle, A. E. Daigle, ANNE DAIGLE, Anne Daigle, Anne E. Daigle

Publications

641

Citations

H-Index

Concepts

All Affiliations

Response Technologies (United States)Response Biomedical (Canada)University of Southern California Graduate Hospital University of Minnesota

About

Anne E. Daigle is an author at Response Technologies (United States) specializing in medicine, hiv, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	380
2	Public Health	2	2	296
3	Allergy	1	1	18
4	Biostatistics	1	1	100
5	Child Development	1	1	196

Anne E. Daigle

Publications

614

Citations

H-Index

Page 1

	Year	Citations
Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the childrens cancer study group) Leslie L. Robison, Jonathan D. Buckley, Anne E. Daigle, Cancer Epidemiologic InvestigationFamily MedicineRelative RiskPharmacotherapyIndex Pregnancy	1989	196
CONTROL SELECTION USING RANDOM DIGIT DIALING FOR CASES OF CHILDHOOD CANCER1 Leslie L. Robison, Anne E. Daigle American Journal of Epidemiology Cancer ManagementEpidemiology Of CancerPathologyPopulation Health SciencesCancer Registration	1984	100
Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells Richard Trauger, F. Ferré, Anne E. Daigle, The Journal of Infectious Diseases	1994	74
Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up Alexandra M. Levine, Susan Groshen, J. R. Allen, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology	1996	57
HIV-1 immunogen induction of HIV-1-specific delayed-type hypersensitivity John L. Turner, Richard Trauger, Anne E. Daigle, AIDS	1994	32
The effects of an HIV‐1 immunogen (Remune) on viral load, CD4 cell counts and HIV‐specific immunity in a double‐blind, randomized, adjuvant‐controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs J R Turner, JR Kostman, Alessandra Aquino, HIV Medicine	2001	29
Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia William G. Woods, Anne E. Daigle, Raymond J. Hutchinson, The Journal of Pediatrics Hematological MalignancyAntibioticsPediatric HematologyMaintenance PhaseMixed-phenotype Acute Leukemia	1984	28
Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection Ronald B. Moss, Richard Trauger, Wieslawa Giermakowska, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology	1997	28
Viral load in peripheral blood mononuclear cells as surrogate for clinical progression. F. Ferré, Ronald B. Moss, Anne E. Daigle, PubMed Surrogate MarkersViral PathogenesisImmunologyPathologyClinical Progression	1995	19
Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial. Richard Trauger, Anne E. Daigle, Wieslawa Giermakowska, PubMed Inactivated Hiv-1 ImmunogenImmunologyImmunodominanceInactivated Hiv-1 AntigenImmunotherapeutics	1995	19

Page 1